
Ravi Tripathi
Hi, I completed my Ph.D. in Dr. Binghe Wang's lab in the Department of Chemistry at Georgia State University. My research projects focus on developing novel strategies to deliver organic carbon monoxide (CO) prodrugs facilitating the future development of CO-based therapeutics. In addition, I am also actively involved in the design and development of small molecules for cancer therapy. I am proficient in the characterization, purification, and biological evaluation of organic molecules, employing advanced research techniques such as spectroscopy and flow cytometry. I love to go hiking, bowling, and playing tennis, pickleball, and badminton in my spare time.

Ravi Tripathi Earns a Doctor of Philosophy degree in Organic Chemistry
Ravi Tripathi of Atlanta earned a Doctor of Philosophy degree in Organic Chemistry from Georgia State University during the Summer 2023 semester. More than 2,000 students earned degrees at the ass...
January, 29 2024 - Verified by Georgia State University
Ravi Tripathi Receives Medicinal Chemistry Fellowship
Georgia State University student Ravi Tripathi recently received the David W. Boykin Graduate Fellowship in Medicinal Chemistry. Tripathi, of Atlanta, is a Ph.D. student in the College of Arts an...
May, 09 2023 - Verified by Georgia State University
Ravi Tripathi Presents Researchat Conference for Research, Scholarship, and Creative Activity.
Georgia State University student Ravi Tripathi recently presented research at Georgia State University's Graduate Conference for Research, Scholarship, and Creative Activity. Tripathi, of Deoria, ...
December, 08 2022 - Verified by Georgia State University
American Chemical Society
An active member of the prestigious society
Georgia State University
Added by Ravi
Graduate Research Assistant at Georgia State University
January 2018 - September 2020
Pharmacovigilance Associate at Wipro Ltd.
October 2014 - February 2015
Biotin conjugates in targeted drug delivery: is it mediated by a biotin transporter, a yet to be identified receptor, or (an)other unknown mechanism(s)?
Conjugation of drugs with biotin is a widely studied strategy for targeted drug delivery. The structure–activity relationship (SAR) studies through H3-biotin competition experiments conclude with the presence of a free carboxylic acid being essential for its uptake via the sodium-dependent multivitamin transporter (SMVT, the major biotin transporter). However, biotin conjugation with a payload requires modification of the carboxylic acid to an amide or ester group. Then, there is the question as to how/whether the uptake of biotin conjugates goes through the SMVT. If not, then what is the mechanism? Herein, we present known uptake mechanisms of biotin and its applications reported in the literature. We also critically analyse possible uptake mechanism(s) of biotin conjugates to address the disconnect between the results from SMVT-based SAR and “biotin-facilitated” targeted drug delivery. We believe understanding the uptake mechanism of biotin conjugates is critical for their future applications and further development.
November 2023 -
Articles
Toward “CO in a Pill”: Silica-Immobilized Organic CO Prodrugs for Studying the Feasibility of Systemic Delivery of CO via In Situ Gastrointestinal CO Release
Mol. Pharmaceutics, ACS Publications
doi.org/10.1021/acs.molpharmaceut.2c01104
February 2023 -
Publications
De Novo Construction of Fluorophores via CO Insertion-Initiated Lactamization: A Chemical Strategy toward Highly Sensitive and Highly Selective Turn-On Fluorescent Probes for Carbon Monoxide
J Am Chem Soc. 2022 Dec 22. doi: 10.1021/jacs.2c07504. Epub ahead of print. PMID: 36548940.
December 2022 -
Publications
Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core
Poster Presentation at CGHI Innovation Summit, Atlanta
October 2022 -
Conferences
Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core
J Enzyme Inhib Med Chem. 2022;37(1):2370-2381
August 2022 -
Publications
Light-Activated CO Donor as a Universal CO Surrogate for Pd-Catalyzed and Light-Mediated Carbonylation
Org. Lett. 2022, 24, 27, 4902–4907
July 2022 -
Publications
Carbon Monoxide as a Therapeutic for Airway Diseases: Contrast and Comparison of Various CO Delivery Modalities
Curr Top Med Chem. 2021;21(32):2890-2908
December 2021 -
Publications
Chemical Reactivities of Two Widely Used Ruthenium-Based CO-Releasing Molecules with a Range of Biologically Important Reagents and Molecules
Anal. Chem. 2021, 93, 12, 5317–5326
March 2021 -
Publications
Inducing Apoptosis through Upregulation of p53: Structure-Activity Exploration of Anthraquinone Analogs
Med Chem Res. 2020 Jul;29(7):1199-1210
June 2020 -
Publications
Resume